Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80,437,135
-
Number of holders
-
189
-
Total 13F shares, excl. options
-
71,012,920
-
Shares change
-
+2,643,225
-
Total reported value, excl. options
-
$3,320,619,406
-
Value change
-
+$114,326,210
-
Put/Call ratio
-
67.8%
-
Number of buys
-
83
-
Number of sells
-
-99
-
Price
-
$46.75
Significant Holders of PTC THERAPEUTICS, INC. - Common Stock (PTCT) as of Q3 2020
237 filings reported holding PTCT - PTC THERAPEUTICS, INC. - Common Stock as of Q3 2020.
PTC THERAPEUTICS, INC. - Common Stock (PTCT) has 189 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71,012,920 shares
of 80,437,135 outstanding shares and own 88.3% of the company stock.
Largest 10 shareholders include FMR LLC (10,133,976 shares), WELLINGTON MANAGEMENT GROUP LLP (9,472,736 shares), VANGUARD GROUP INC (5,827,812 shares), BlackRock Inc. (5,742,425 shares), FRANKLIN RESOURCES INC (5,572,250 shares), RTW INVESTMENTS, LP (3,993,286 shares), STATE STREET CORP (2,283,608 shares), PRICE T ROWE ASSOCIATES INC /MD/ (2,269,517 shares), JANUS HENDERSON GROUP PLC (2,018,563 shares), and ALLIANCEBERNSTEIN L.P. (1,738,658 shares).
This table shows the top 189 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.